BSX
Price
$73.30
Change
+$0.44 (+0.60%)
Updated
Apr 25, 6:59 PM EST
90 days until earnings call
EW
Price
$88.01
Change
-$0.61 (-0.69%)
Updated
Apr 25, 6:59 PM EST
Earnings call today
Ad is loading...

BSX vs EW ᐉ Comparison: Which is Better to Invest?

Header iconBSX vs EW Comparison
Open Charts BSX vs EWBanner chart's image
Boston Scientific
Price$73.30
Change+$0.44 (+0.60%)
Volume$3.17M
CapitalizationN/A
Edwards Lifesciences
Price$88.01
Change-$0.61 (-0.69%)
Volume$1.33M
CapitalizationN/A
View a ticker or compare two or three
BSX vs EW Comparison Chart

Loading...

BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EWDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BSX vs. EW commentary
Apr 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and EW is a Hold.

COMPARISON
Comparison
Apr 26, 2024
Stock price -- (BSX: $72.91 vs. EW: $88.61)
Brand notoriety: BSX and EW are both notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BSX: 251% vs. EW: 92%
Market capitalization -- BSX: $100.1B vs. EW: $57.52B
BSX [@Medical Specialties] is valued at $100.1B. EW’s [@Medical Specialties] market capitalization is $57.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.42B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 2 FA rating(s) are green whileEW’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 2 green, 3 red.
  • EW’s FA Score: 0 green, 5 red.
According to our system of comparison, EW is a better buy in the long-term than BSX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 4 TA indicator(s) are bullish while EW’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 4 bullish, 4 bearish.
  • EW’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BSX is a better buy in the short-term than EW.

Price Growth

BSX (@Medical Specialties) experienced а +7.28% price change this week, while EW (@Medical Specialties) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.48%. For the same industry, the average monthly price growth was -0.49%, and the average quarterly price growth was +16.66%.

Reported Earning Dates

BSX is expected to report earnings on Jul 24, 2024.

EW is expected to report earnings on Jul 25, 2024.

Industries' Descriptions

@Medical Specialties (+3.48% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for BSX with price predictions.
OPEN
A.I.dvisor published
a Summary for EW with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than EW($57.5B). BSX has higher P/E ratio than EW: BSX (63.64) vs EW (40.98). BSX YTD gains are higher at: 26.120 vs. EW (16.210). BSX has higher annual earnings (EBITDA): 3.45B vs. EW (1.76B). EW has more cash in the bank: 1.64B vs. BSX (865M). EW has less debt than BSX: EW (695M) vs BSX (9.49B). BSX has higher revenues than EW: BSX (14.2B) vs EW (6.01B).
BSXEWBSX / EW
Capitalization100B57.5B174%
EBITDA3.45B1.76B196%
Gain YTD26.12016.210161%
P/E Ratio63.6440.98155%
Revenue14.2B6.01B236%
Total Cash865M1.64B53%
Total Debt9.49B695M1,366%
FUNDAMENTALS RATINGS
BSX vs EW: Fundamental Ratings
BSX
EW
OUTLOOK RATING
1..100
7363
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
1560
SMR RATING
1..100
7643
PRICE GROWTH RATING
1..100
944
P/E GROWTH RATING
1..100
8950
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BSX's Valuation (82) in the Medical Specialties industry is in the same range as EW (85). This means that BSX’s stock grew similarly to EW’s over the last 12 months.

BSX's Profit vs Risk Rating (15) in the Medical Specialties industry is somewhat better than the same rating for EW (60). This means that BSX’s stock grew somewhat faster than EW’s over the last 12 months.

EW's SMR Rating (43) in the Medical Specialties industry is somewhat better than the same rating for BSX (76). This means that EW’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Price Growth Rating (9) in the Medical Specialties industry is somewhat better than the same rating for EW (44). This means that BSX’s stock grew somewhat faster than EW’s over the last 12 months.

EW's P/E Growth Rating (50) in the Medical Specialties industry is somewhat better than the same rating for BSX (89). This means that EW’s stock grew somewhat faster than BSX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXEW
RSI
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
55%
MACD
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
Declines
ODDS (%)
Bearish Trend 7 days ago
48%
Bearish Trend 7 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
BSXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
EWDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIP26.150.03
+0.11%
TripAdvisor
GDTC2.15N/A
N/A
CytoMed Therapeutics Limited
XBIT8.07-0.11
-1.34%
XBiotech
ACEL11.50-0.18
-1.54%
Accel Entertainment
FTV76.05-4.65
-5.76%
Fortive Corp

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been loosely correlated with SYK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if BSX jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+5.68%
SYK - BSX
66%
Loosely correlated
+0.58%
RVTY - BSX
52%
Loosely correlated
-0.79%
ISRG - BSX
52%
Loosely correlated
-0.55%
ZBH - BSX
51%
Loosely correlated
-0.29%
PEN - BSX
45%
Loosely correlated
+0.22%
More